Rising Pharmaceuticals launches Edetate calcium disodium injection, alleviating US shortage
Rising Pharmaceuticals, a key player under the Rising Pharma Holdings Inc. umbrella, has triumphantly announced the approval and immediate market release of its Edetate calcium disodium injection. This much-anticipated launch aims to fill the significant therapy void, addressing the pressing commercial shortage of this vital treatment in the US. This injection, developed by Rising Pharmaceuticals, […]